Sarepta Therapeutics, Inc.
$2.27B- Market cap
- $2.38B
- Debt
- +$828.97M
- Cash
- −$939.65M
Capital structure 74% equity / 26% debt · EV / Revenue 1.03x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
SRPT · current priceP/S 1.08x
$22.50Latest market snapshot
Implied fair value · at PEG's multiple
$62.83179.2% above market
20.81 SRPT revenue / share×3.02x PEG P/S=$62.83
Market $22.50Implied $62.83
PEG · current priceP/S 3.02x
$73.70Latest market snapshot
Implied fair value · at SRPT's multiple
$26.3964.2% below market
24.41 PEG revenue / share×1.08x SRPT P/S=$26.39
Market $73.70Implied $26.39